Filters
Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US
Press Release, Product
Hikma’s diversified business delivers resilient H1 performance
Press Release, Corporate
Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region
Press Release, Corporate
Hikma enters the French generic injectables market, expanding European presence
Press Release, Corporate
Siggi Olafsson to step down as Chief Executive
Press Release, Corporate
Section 430(2B) Companies Act 2006 Statement
Press Release, Corporate
Hikma updates Generics guidance for 2022
Press Release, Inside Information
Continued strategic progress and updated full year guidance following Custopharm acquisition
Press Release, Corporate
Hikma completes acquisition of Custopharm
Press Release, Corporate
Hikma confirms FTC preliminary approval for Custopharm
Press Release, Corporate
Hikma Ventures leads seed financing round for Egypt based O7 Therapy; a mental health service provider for Arabic-speake...
Press Release, Corporate
Hikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companies
Press Release, Corporate
Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi to Expand the Platform’s Reach across MENA
Press Release, Corporate
Hikma launches Benztropine Mesylate Injection, USP
Press Release, Product